Posted by Michael Wonder on 06 Nov 2021
Novavax files COVID-19 vaccine for emergency use listing with World Health Organization
4 November 2021 - All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO.
Novavax today announced the completion of its rolling submission to the World Health Organization for emergency use listing of NVX-CoV2373, its COVID-19 vaccine candidate.
